CAMK2G and Alzheimer disease: Taken together, previous studies and the findings reported here suggest that Ca2+ dysregulation in AD, and LBD within selected brain regions, may be sufficient to initiate a deregulation in CaMKII- and Dynamin1-dependent molecular pathways, and that this, in turn, may contribute to cognitive decline.